Blood Products Market: By Type (Whole Blood, Blood Components, Blood Derivatives), By Product (Packed RBC’s, Platelets, FFP, Cryo, Washed Red Blood Cells, Irradiated Blood) By Application (Treatment, Diagnosis), By End User (Blood Banks, Diagnostic Centres, Hospitals),  By Geography

 

Global blood products market have plentiful of market players and it is consolidated. In terms of processing devices, strong market players are present. Companies in this market are focusing on new product develepments and market expansions for strengthen their market share. These are classified blood components arranged in the blood transfusion focus (red cells, platelets, crisp solidified plasma and cryoprecipitate) or plasma subsidiaries produced from pooled plasma gifts in plasma fractionation focuses, (for example, egg whites, coagulation components and immunoglobulins). Furthermore companies are also stregnthening their posistion by acquiring the other companies operating in same market. For instance, in August 2012, Haemonetics Corporation acquired business assets of blood collection, filteration and processing product lines of Pall Corpration. On November 11, 2013, Grifols, a global healthcare company and producer of plasma therapies, acquired the transfusion diagnostics unit of Novartis. Furthermore, government organizations and non-government organizations are also playing major role in providing awareness regarding life threatening diseases, blood transfusion, blood donation etc.